Kaverina N V, Katsenovich R A, Tkachenko B I, Iunusov Z Z, Ovsiannikov V I
Farmakol Toksikol. 1985 Jan-Feb;48(1):23-7.
It has been demonstrated clinically and experimentally that administration of nonachlazine enhances myocardial contractility because of the stimulation of beta-adrenostructures and that the initial status of the latter ones determines in many respects the drug action intensity.
临床和实验均已证明,给予去甲氯氮卓可增强心肌收缩力,因为它能刺激β-肾上腺素结构,而且后者的初始状态在很多方面决定了药物作用的强度。